Grifols SA (GRFS)
7.34
+0.01
(+0.14%)
USD |
NASDAQ |
Jun 09, 16:00
7.34
0.00 (0.00%)
Pre-Market: 08:47
Grifols EPS Diluted (Quarterly) : 0.1255 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.501 |
| Cellectis SA | -0.1774 |
| Autolus Therapeutics Plc | -0.2686 |
| Akari Therapeutics Plc | -9.584 |
| Evaxion AS | -0.4366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 102.95M |
| Revenue (Quarterly) | 1.989B |
| Total Expenses (Quarterly) | 1.903B |
| Enterprise Value | 14.98B |
| Gross Profit Margin (Quarterly) | 36.47% |
| Profit Margin (Quarterly) | 5.18% |
| Earnings Yield | 9.63% |
| Operating Earnings Yield | 28.41% |
| Normalized Earnings Yield | 9.221 |